The symposium will highlight the current state of research on rare health conditions from various perspectives, including health economics and legal aspects, as well as the viewpoints of patients and families.
PROGRAM
10:00 Welcome from Sahlgrenska Academy, Magnus SimrĂ©n, Professor, Medical Gastroenterology, University 91̀½»¨.
10:05 Goals for the day, Anders Olauson, newly appointed Honorary Doctor of Medicine, University 91̀½»¨.
10:15 Health economics, John Bridges, Professor, Biomedical Informatics and Surgery, Ohio State University.
10:45 Legal frameworks for patient pathways, Ulf Petrusson, Professor, Law, University 91̀½»¨.
11:15 Looking ahead, Anders Olauson.
11:35 The Ă…²µ°ù±đ²Ô²ơ°́²¹ Model, Zozan Sewger Kvist, CEO, Ă…²µ°ù±đ²Ô²ơ°́²¹ Benefit Corporation.
11:50 The Gothenburg Initiative, Kate Abrahamsson, Professor of Pediatric Surgery at University 91̀½»¨ and Director of Queen Silvia Children’s Hospital.
12:10 Living in between a patient journey and the patient pathway, Rebecca Tvedt Skarberg, Norwegian Advisory Unit on Rare Disease at Oslo University Hospital, and patient advocate EURORDIS and ERN BOND.
12:30 Key takeaways, Jovanna Dahlgren, Professor, Pediatric Endocrinology, University 91̀½»¨.
12:45 Refreshments and snacks.
Moderator: Jovanna Dahlgren.
If you have any questions, contact: : klinvet@gu.se